New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection

By S. Dollard, S. Grosse, D. S. Ross. Reviews in Medical Virology, 2007

1,212 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. (2010, neutral): “palsy [3, 4].”
The “Silent” Global Burden of Congenital Cytomegalovirus (2013, background): “ment has been reported in 7% to 10% (44, 62) of such infants,”
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection (2010, background): “Congenital infection with CMV is a major cause of sensorineural hearing loss and neurological impairments [3–5].”
Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease (2015, neutral): “10% of congenitally infected neonates have symptomatic disease at delivery, of whom 35% have SNHL, up to two-thirds have neurologic deficits, and 4% die in the newborn period.(7-11) Overall, congenital CMV is a rare infection but accounts for 21% of hearing loss at birth and 24% of hearing loss at f”